We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$4.65B
AUM Growth
-$902M
Cap. Flow
-$55.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
17.2%
Holding
1,576
New
113
Increased
560
Reduced
639
Closed
173

Top Buys

Rank Stock Value
1
SJNK icon
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
+$11.4M
2
XLRE icon
State Street Real Estate Select Sector SPDR ETF
XLRE
+$10.4M
3
WBD icon
Warner Bros
WBD
+$7.05M
4
VUSB icon
Vanguard Ultra-Short Bond ETF
VUSB
+$6.7M
5
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$6.27M

Top Sells

Rank Stock Value
1
SGOL icon
abrdn Physical Gold Shares ETF
SGOL
+$12.8M
2
AAPL icon
Apple
AAPL
+$7.91M
3
SPHB icon
Invesco S&P 500 High Beta ETF
SPHB
+$7.88M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$7.62M
5
FCN icon
FTI Consulting
FCN
+$6.61M

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Healthcare 11.48%
3 Financials 11.22%
4 Industrials 8.07%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTG icon
1376
B2Gold
BTG
$5B
$35K ﹤0.01%
+10,256
New +$42.8K
CGEN icon
1377
Compugen
CGEN
$222M
$31K ﹤0.01%
16,500
– –
NVTA
1378
DELISTED
Invitae Corporation
NVTA
$30K ﹤0.01%
+12,250
New +$54.2K
MREO
1379
Mereo BioPharma
MREO
$54.7M
$29K ﹤0.01%
26,000
+6,000
+30% +$4.65K
NGD
1380
DELISTED
New Gold Inc
NGD
$29K ﹤0.01%
27,196
+125
+0.5% +$179
AQB icon
1381
AquaBounty Technologies
AQB
$4.66M
$27K ﹤0.01%
782
-275
-26% -$8.4K
CURI icon
1382
CuriosityStream
CURI
$145M
$26K ﹤0.01%
15,300
– –
MBIO icon
1383
Mustang Bio
MBIO
$4.32M
$26K ﹤0.01%
60
– –
IEAWW
1384
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$26K ﹤0.01%
25,000
– –
FIRY
1385
Firy Inc
FIRY
$148M
$21K ﹤0.01%
843
-5
-0.6% -$195
PGEN icon
1386
Precigen
PGEN
$2.24B
$20K ﹤0.01%
14,900
-5,900
-28% -$8.75K
PVLA
1387
Palvella Therapeutics
PVLA
$1.99B
$20K ﹤0.01%
131
– –
IAG icon
1388
IAMGOLD
IAG
$8.2B
$19K ﹤0.01%
+11,755
New +$29.6K
KALA icon
1389
KALA BIO
KALA
$14.1M
$18K ﹤0.01%
25
+13
+108% +$20.4K
SLNO
1390
DELISTED
Soleno Therapeutics
SLNO
$18K ﹤0.01%
6,537
-8,934
-58% -$24.7K
SURF
1391
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$18K ﹤0.01%
11,049
– –
NBSE
1392
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$17K ﹤0.01%
788
– –
BARK icon
1393
BARK
BARK
$81.8M
$16K ﹤0.01%
625
-331
-35% -$16.7K
WATT icon
1394
Energous
WATT
$77.6M
$15K ﹤0.01%
25
– –
OTLK icon
1395
Outlook Therapeutics
OTLK
$183M
$14K ﹤0.01%
+700
New +$20.1K
WRN
1396
Western Copper and Gold
WRN
$460M
$13K ﹤0.01%
10,000
– –
MTEM
1397
DELISTED
Molecular Templates, Inc.
MTEM
$9K ﹤0.01%
667
– –
CD
1398
Chaince Digital Holdings
CD
$222M
$8K ﹤0.01%
+11,250
New +$18.5K
DFTX
1399
Definium Therapeutics
DFTX
$5.78B
$8K ﹤0.01%
854
-1
-0.1% -$13
ORTX
1400
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$8K ﹤0.01%
1,410
+250
+22% +$1.41K
54 55
56
57 58

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Oppenheimer & Co held 1,576 positions worth $4.65B, down 16% from $5.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q2 2022 filing shows 113 new, 560 increased, 639 reduced and 173 closed positions. Its largest new stake was Warner Bros: 379,857 shares worth $5.1M. The largest sale was abrdn Physical Gold Shares ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2022 buy was Warner Bros: 379,857 shares worth $5.1M.
  • Oppenheimer & Co added most to State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2022, an estimated $11.4M increase.
  • Oppenheimer & Co's biggest Q2 2022 reduction was Apple, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited abrdn Physical Gold Shares ETF in Q2 2022, selling an estimated $12.8M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.65B portfolio in Q2 2022.
  • Oppenheimer & Co opened 113 new positions and closed 173 in Q2 2022.
  • Oppenheimer & Co's portfolio value fell 16% quarter-over-quarter to $4.65B.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.